Article info
PDFClinical and epidemiological research
Extended report
Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden
- Correspondence to Dr Hjalmar Wadström, Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, SE 171-76, Sweden; hjalmar.wadstrom{at}ki.se
Citation
Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden
Publication history
- Received July 16, 2015
- Revised November 1, 2015
- Accepted December 14, 2015
- First published January 11, 2016.
Online issue publication
June 10, 2016
Article Versions
- Previous version (11 January 2016).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Data supplement 1 - Online supplement
Lay summary
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/